Clinical Innovation Sandbox
Innovative studies around the world face numerous challenges throughout their clinical trial workflow.
50% of all clinical trials are delayed due to recruitment issues, challenges around data privacy and security, slow regulatory approval framework and challenges in securing a clinical trial ecosystem leads to slow adoption of the innovative studies.
The clinical innovation sandbox initiative aims to accelerate the studies by overcoming these challenges.
Partnership with Research and Innovation Circle of Hyderabad (RICH) will benefit the innovators with 15 clinical sites guidance from experienced professionals and mentors to navigate the complexities of clinical validation and market entry.
Accelerate validation and regulatory process
Fast tracking the approval and making products to reach market (India and global) faster
Address slow adoption of innovative clinical trials
Boosting the clinical trials infrastructure and workforce training in India and achieving far reaching global effects by running Biomarker, SaMD and Decentralized Trials
Establish strategic partnerships
Bridging the gaps innovative studies to be “first in class and act as benchmark” through alliance with technology providers, industry partners, CROs etc.